Figure 1.
The workflow for inclusion of drugs in established and newly-approved drug lists. The metabolism pathways were analyzed using the unique compounds from “top 200” most prescribed medications in 2014 (established drugs; n=165) as well as FDA approved drugs from “2005–2016” (newly-approved drugs; n=249). n, denotes the number of compounds analyzed at each stage.